Reuters logo
BRIEF-Strides Shasun says EMA recommendation for suspension of 300 drugs to not have any impact on co's ops
March 27, 2017 / 4:44 AM / 8 months ago

BRIEF-Strides Shasun says EMA recommendation for suspension of 300 drugs to not have any impact on co's ops

March 27 (Reuters) - Strides Shasun Ltd:

* Clarifies on news item on recommendation by European Medicines Agency (EMA) for suspension of 300 drugs

* Co has only one drug in 5 markets and said product has not been commercialized

* Co confirms that recommendation will not have any impact on operations and financials of co Source text: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below